
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Jill Stopfer, from the University of Pennsylvania, discusses the benefits of multigene panel testing.
Jill Stopfer, senior genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses the benefits of multigene panel testing.




